Real world challenges and disparities in the systemic treatment of ovarian cancer

Ovarian cancer (OC) is a global health problem, and the mortality-to-incidence ratio is expected to increase, especially in low- and middle-income countries. These regions face disparities in access to OC care, including lack of awareness, limited access to genetic and tumor testing, paucity of surgical expertise, time to approval of novel therapeutics, and treatment costs. By addressing these inequities, the core aim of this paper is to promote action through collaboration in order to overcome these barriers and promote health equity in OC management and treatment. •Rising mortality to incidence ratio in ovarian cancer is expected, related to limited access in low and middle income areas.•Data reflecting population heterogeneity, genetic testing, drug access, and clinical trial diversity need to be prioritized.•Unite international team of health care providers in order to promote global equity in ovarian cancer care.